About the Alzheimers and Parkinsons Diseases Session
Alzheimer's disease is a progressive brain disease that takes a toll on memory and thinking skills, as well as the capacity to carry out even the most basic tasks. Symptoms of Alzheimer's disease usually show later in life in most persons. Experts estimate that more than 6 million Americans, the majority of whom are 65 or older, may have dementia caused by Alzheimer's disease. Alzheimer's disease is now the sixth biggest cause of mortality in the United States, but new estimates suggest it may be in third place, just after heart disease and cancer, as a cause of death among the elderly.
Parkinson's disease (PD) is a neurodegenerative condition that primarily affects dopamine-producing ("dopaminergic") neurons in the substantia nigra region of the brain. Symptoms usually appear gradually over time. Because of the variability of the condition, the course of symptoms varies from one person to the next. The cause is still a mystery. Although there is no cure, there are a variety of treatment options available, including drugs and surgery. While Parkinson's disease is not lethal in and of itself, it can cause catastrophic complications. Complications from Parkinson's disease are the 14th leading cause of mortality in the United States, according to the Centers for Disease Control and Prevention (CDC).
- Multiple System Atrophy (MSA)
- Progressive Supranuclear Palsy (PSP)
- Corticobasal Syndrome (CBS)
- Dementia with Lewy bodies (DLB)
- Drug-induced Parkinsonism.
- Vascular Parkinsonism (VP)
Featured Speakers — Alzheimers and Parkinsons Diseases 2027
Speaker lineup for this track will be announced soon.
Browse all speakers →Recent Research Presented at Alzheimers and Parkinsons Diseases Sessions
Selected abstracts from this track will be published here.
Related Scientific Sessions at Neurology 2027
Why Attend the Alzheimers and Parkinsons Diseases Conference 2027
Present Your Research
Oral and poster slots for original Alzheimers and Parkinsons Diseases work, reviewed by the scientific committee.
Network Globally
Meet researchers, academics, and practitioners from around the world throughout the conference.
Learn from Keynotes
Plenary lectures from leading voices shaping Alzheimers and Parkinsons Diseases research and practice.
Hybrid Flexibility
Attend in person in Rome or join virtually — same program, same certificate.
Join Neurology 2027 for the Alzheimers and Parkinsons Diseases track
Oral and poster slots for your work — in person in Rome or online. Not presenting? Attend as a delegate to learn from the field.
Alzheimers and Parkinsons Diseases Conference 2027 — FAQs
What is the Alzheimers and Parkinsons Diseases track at Neurology 2027?
The Alzheimers and Parkinsons Diseases track is a dedicated stream within Neurology 2027 covering the latest research, innovation, and best practice in Alzheimers and Parkinsons Diseases. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Who should attend the Alzheimers and Parkinsons Diseases sessions?
Researchers, academics, practitioners, doctoral students, and industry professionals with an interest in Alzheimers and Parkinsons Diseases are all welcome — whether presenting or attending.
Can I present my research in the Alzheimers and Parkinsons Diseases track?
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee.
Is virtual attendance available for Alzheimers and Parkinsons Diseases sessions?
Yes. Neurology 2027 is a hybrid conference — attend the Alzheimers and Parkinsons Diseases track in person in Rome or join live online, with on-demand access afterward.
Join the Neurology 2027 delegation
Rome · June 24–26, 2027· Hybrid · in-person & virtual
Attend without presenting.